1. The present study examined if the presence of creatine kinase (CK) inhibitors might explain the large variability in blood levels of CK among subjects after exercise-induced muscle damage.
INTRODUCTION
Blood levels of creatine kinase (CK) are commonly used in the diagnosis of myocardial infarction and several myopathies such as Duchenne dystrophy [ 1-41, Cardiac or skeletal muscle damage is suspected or indicated by the presence of elevated CK activity in the blood. Several studies have shown that serum or plasma CK activity increases dramatically after strenuous or novel physical exercise [5-111, and this increase has been considered evidence of exercise-induced muscle damage. In this regard, use of an exercise model may be appropriate in the study of muscle damage and repair processes in healthy human subjects.
A problem with the use of CK in the blood as an indicator of muscle damage is that CK demonstrates a large inter-subject variability [lo, [12] [13] [14] . This is a particular problem in using CK as a serum or plasma marker of exercise-induced muscle damage. For example, in one study where subjects performed an eccentric exercise, some subjects showed increases of CK activity up to 30000 m-units/ml, while other subjects showed increases of less than 500 m-units/ml [lo] . In studies from our laboratory, where we have monitored CK activity after various forms of strenuous exercise, we have found high responders, whose increase in CK activity is far above the mean, and no responders, who demonstrate no increase [6, 121. This variability is puzzling, since in most cases it is unrelated to the general fitness of the subjects, the physical characteristics of the subjects, the amount of soreness that is induced by the exercise, and the amount of work done in the exercise. At present there is no clear explanation for this phenomenon.
Serum or plasma CK levels have also been used to assess rapid adaptation to exercise-induced muscle damage [6, 7, [15] [16] [17] . When an exercise is repeated from one to six weeks after the initial bout, with no intervening exercise, the increase in CK after the second bout of exercise is severely diminished [6] . A strengthening of the muscle or connective tissue has been suggested to explain this rapid adaptation [ 171. However, the mechanism responsible for such a rapid adaptation is unclear.
Recently, Kagen & Aram [18] reported that sera from certain patients with muscle disease contained a dialysable inhibitor of CK which resulted in a large underestimation of actual CK levels. When serum from one patient was mixed with an equal volume of serum from another patient, there was a greater than 50% reduction in the expected total CK activity. They concluded that for certain patients, CK inhibitors may be released into the blood from injured or damaged muscle. The purpose of the present study was to ( 1 ) examine if the presence of CK inhibitors might explain the large variability in blood levels of CK among subjects after exercise-induced muscle damage, and (2) to examine if the lower CK response after the second bout may be due in part to an adaptation such that there is a release of CK inhibitors from the tissue.
METHODS
Twenty-four women participated in the study and signed an informed consent document consistent with the University guidelines for the protection of human subjects. All subjects performed 70 maximal eccentric contractions using the forearm flexor muscles of the non-dominant arm. This exercise is described in more detail elsewhere [7] . For five days after the exercise, serum CK activity was monitored. On the fifth day five of these subjects showed no increase in CK ( < 200 m-units/ml), five subjects demonstrated increases of 300-600 m-units/ml, and 14 subjects demonstrated an increase of over 1000 munits/ml. Of these subjects, four of the 'no CK responders', five of the 'high CK responders' and two of the 'low CK responders' were chosen for further analysis. The mean ( f SD) age, height and weight of the no CK responders was 19 ( f 1.4) years, 159 ( -t 4.0) cm, and 52 ( f 5.0) kg, respectively, of the low CK responders 20 ( k 0 . 7 ) years, 169 ( f 5.6) cm, and 57 ( -t 2.1) kg, respectively, and of the high CK responders 22 ( k 4.5) years, 168 ( Ifr 2.9) cm and 59 ( -t 6.2) kg, respectively.
We have found in several previous studies [6, 7, 15 ] that both high and low CK responders show a repeated bout effect; therefore, in this study only high CK responders repeated the same exercise two weeks after the first bout. In addition to serum CK, isometric force generation and muscle soreness were measured before and for five days after each of the exercises.
Blood samples were drawn by venepuncture from the cubital fossa region of the arm into a serum separation tube. The blood was allowed to clot for 10 min at room temperature and then centrifuged for 10 min to separate the serum. After separation, all serum samples were frozen at -20°C until analysis of CK activity. CK activity was assessed in duplicate samples by the method of Szasz et al. [ 191 with a Sigma test kit.
Isometric force generation was assessed while subjects were seated at an arm curl machine. The lever arm was fixed so that the elbow angle was at 90 degrees. A strain gauge was connected from the lever arm to a stationary support and output from the strain gauge was displayed on a pen recorder. The mean of three strength trials was used as the criterion score. Muscle soreness was assessed by questionnaire on a scale of one (normal) to 10 (very sore).
To determine if CK inhibitors were present, the method of Kagen & Aram [18] was used. In this procedure, two sera were mixed together in equal volumes and then analysed for CK activity. If no CK inhibitors were present, the resulting CK activity would equal the sum of the activity from both of the sera. Kagen & Aram [ 181 found that urate, cysteine and cystine were not responsible for the CK inhibitor activity. Thus, these agents were not a concern in our study. In part one of the study, sera from subjects who demonstrated a large increase in CK were mixed with sera from subjects who demonstrated little or no increase in CK. For each mix, serum obtained on day one, two or four after exercise from a no CK responder or low CK responder was added to serum obtained on day four from a high CK responder. In part two of the study, sera were mixed such that the bout onelday four sera were mixed with sera taken from the same subject after bout two. In this way, bout onelday four sera were mixed with bout two/day one, bout two/ day two, and bout two/day four sera.
RESULTS
The increase in CK activity for the subjects is presented in Fig. 1 . Force generation decreased immediately after exercise and was not completely restored by day five after exercise. There was no consistent pattern of strength loss among the three groups. All of the high and low CK responders demonstrated at least 50% loss in strength, and two of the no CK responders showed strength losses of 67% and 54%.
Soreness increased to peak values between 24 and 48 h after the exercise. There was considerable overlap in the CK response among the three groups. For example, one of the high CK responders reported a soreness value of four on day one and then little or no soreness for days two, three, four and five after exercise. Also, one no CK responder and one low CK responder reported soreness values of six and seven on days one and two, respectively.
Data from the mixed sera are presented in Table 1 . When the low CK responder or no CK responder serum from day one, two or four after exercise was mixed with serum from day four of a high CK responder, differences between the expected and observed total CK activity were within the expected variability for the assay.
The CK values for the high CK responders who performed a second bout of exercise two weeks after the first bout are presented in Table 2 . While there was a large increase in CK after bout one, there was no increase in CK after bout two. The values for the mix of sera from bout one with that of bout two are also presented in Table  2 . When the bout onelday four sera were mixed with sera from bout two/day one, bout twolday two and bout two/ day four, differences between the expected and observed total CK activity were within the expected variability for the assay.
DISCUSSION
When sera from high CK responders were mixed with sera from either low CK responders or no CK responders, the observed total activity was as expected. Therefore, sera from the low CK responders and the no CK responders did not contain the CK inhibitor that was observed in certain patients with muscle damage [18] . It still remains unclear why such large inter-subject variability exists in the CK response to exercise-induced muscle damage. Apparently some subjects may be more resistant to damage, although the explanation for this is unclear. In previous studies we [6,7, 12,201 and others [lo, 211 have found that the increase in serum CK activity is unrelated to either the development of muscle soreness, the amount of strength loss after exercise, fitness level of the subject, or lean body weight.
Jackson et al.
[ 141 attributed the large CK variability in patients with Duchenne dystrophy to changes in the release of enzymes from the muscle. Kagen & Aram [ 181 found that a dialysable inhibitor of CK activity was present in sera obtained from patients with muscle disease or injury, but not in sera of other individuals. They suggested that the CK inhibitor may be released along with CK into the blood as a result of muscle fibre damage. While this may be the case for disease states, it certainly is not the case in experimentally induced muscle damage.
When high CK responders repeated the exercise two weeks later, all subjects showed a profound reduction in the CK response. While CK values of 1033-5327 m-units/ml were found after bout one, no increase in CK was found after bout two. The adaptation with regard to CK after exercise has been shown to last up to six weeks [6] . Also, prior performance of an exercise with only onefifth to one-third the number of contractions may also produce an adaptation [7] . For example, when an exercise consisting of either 12 maximal contractions (D. Callahan & P.M. Clarkson, unpublished work) or 24 maximal contractions [7] is performed two weeks before an exercise consisting of 70 maximal contractions, the CK response after the 70-contraction exercise is greatly reduced. Therefore, subjects who showed little or no change in CK activity after bout one exercise may have performed some eccentric maximal contractions before participation in our study. We do screen subjects to eliminate those who have recently performed any strenuous or novel exercise. However, since so few contractions may produce an adaptation, and the adaptation can be long lasting, subjects may not have remembered or noticed that they had performed an 'exercise' that would interfere with our study. The present results do show, however, that an adaptation with regard to an increased release of CK inhibitors does not contribute to the reduced CK response after bout two. In summary, the large inter-subject variability in the CK response to exercise cannot be attributed to the presence of CK inhibitors in the sera of those subjects who demonstrate little or no increase in CK after exercise. Also, the profound reduction in the CK response to repeated exercise cannot be attributed to an adaptation whereby the muscle releases CK inhibitors into the serum. Although CK inhibitors have been found in sera from patients with muscle injury and disease, we were unable to demonstrate the presence of CK inhibitors in the sera from subjects who showed evidence of severe exercise-induced muscle damage.
